Letter in response to the recently published review: hyponatremia in cirrhosis and end-stage liver disease--treatment with the vasopressin v2-receptor antagonist tolvaptan.
A
A
Abhyankar
S C
SC
Robson
E B
EB
Tapper
A
A
Bonder
D001552:Benzazepines / Q000627:therapeutic use*; D058625:End Stage Liver Disease / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007010:Hyponatremia / Q000188:drug therapy* / Q000209:etiology*; D008103:Liver Cirrhosis / Q000150:complications* / Q000188:drug therapy*
D001552:Benzazepines